|
Diabetes, Vol 43, Issue 2 305-312, Copyright © 1994 by American Diabetes Association
An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1
NJ Webster, Y Kong, KE Cameron and JL Resnik
Department of Medicine, University of California, San Diego, La Jolla 92093-0673.
We have shown previously that a 500-bp region of the human insulin receptor
promoter (-0.3 to -1.8 kb) was able to stimulate transcription from a
heterologous thymidine kinase promoter in HepG2 hepatoma cells but not in
HeLa fibroblasts. Footprint analysis localized the transcription factor
binding sites to a 36-bp region at -1420. In this paper, we analyze the
factors that recognize this element and show that it contains binding sites
for the CAAT/enhancer binding protein C/EBP and nuclear factor 1 (NF-1). In
addition we show that both C/EBP alpha and the C/EBP beta can transactivate
the human insulin receptor promoter in a dose-dependent manner.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. D. Norquay, X. Yang, Y. Jin, K. A. Detillieux, and P. A. Cattini
Hepatocyte Nuclear Factor-3{alpha} Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function
Mol. Endocrinol.,
March 1, 2006;
20(3):
598 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Vukkadapu, J. M. Belli, K. Ishii, A. G. Jegga, J. J. Hutton, B. J. Aronow, and J. D. Katz
Dynamic interaction between T cell-mediated {beta}-cell damage and {beta}-cell repair in the run up to autoimmune diabetes of the NOD mouse
Physiol Genomics,
April 14, 2005;
21(2):
201 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. BRUNETTI, G. MANFIOLETTI, E. CHIEFARI, I. D. GOLDFINE, and D. FOTI
Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y)
FASEB J,
February 1, 2001;
15(2):
492 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E.-B. Reusch and D. J. Klemm
Editorial: Nutrition and Fat Cell Differentiation
Endocrinology,
July 1, 1999;
140(7):
2935 - 2937.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Lu, J. Seufert, and J. F. Habener
Pancreatic beta -Cell-specific Repression of Insulin Gene Transcription by CCAAT/Enhancer-binding Protein beta . INHIBITORY INTERACTIONS WITH BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR E47
J. Biol. Chem.,
November 7, 1997;
272(45):
28349 - 28359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bortoli, M. Amessou, M. Collinet, B. Desbuquois, and S. Lopez
Vanadate, But Not Insulin, Inhibits Insulin Receptor Gene Expression in Rat Hepatoma Cells
Endocrinology,
November 1, 1997;
138(11):
4821 - 4829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, J. Shao, P. Muhlenkamp, S. Liu, P. Klepcyk, J. Ren, and J. E. Friedman
Increased Insulin Receptor Substrate-1 and Enhanced Skeletal Muscle Insulin Sensitivity in Mice Lacking CCAAT/Enhancer-binding Protein beta
J. Biol. Chem.,
May 5, 2000;
275(19):
14173 - 14181.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|